Sherbini Adham H El, Hasheminia Amin, Gemae Mohamed R, Ansari Farzan, Anood Alqaydi, Saha Tarit, Towe Christopher W, El-Diasty Mohammad
Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
School of Medicine, Queen's University, Kingston, ON, Canada.
Mol Neurobiol. 2025 Apr;62(4):4641-4653. doi: 10.1007/s12035-024-04565-y. Epub 2024 Oct 29.
Chronic post-thoracotomy pain (CPTP) is a major clinical problem that affects up to 35-55% of patients undergoing thoracic incisions. Evidence suggests that multiple cellular signaling pathways and neuro-inflammatory mediators may play an essential role in the pathogenesis of CPTP. In this comprehensive review, we present the current evidence on the cellular signaling pathways and inflammatory changes associated with the initiation and maintenance of CPTP, focusing on the potential application of these findings in the clinical setting. An electronic search of Medline, EMBASE, Cochrane, Google Scholar, and ClinicalTrials.gov was performed, and 3652 abstracts were identified. After an initial abstract screening, 131 studies underwent a full-text review, and nine papers were eventually included in this review. Studies were included if they assessed the cellular signaling pathways or inflammatory processes associated with the induction and/or maintenance of CPTP. All the identified studies were pre-clinical studies conducted on animal models. Our search identified seven cellular pathways (NK-1 receptor (NK-1), Glutaminase 1, Toll-like receptor 4 (TLR4), Resolvins, Ror-2, Sonic hedgehog signaling (Shh), and Wnt5a/Wnts) and six cytokines (IL-1β, IL-6, IL-8, IL-10, IFN-γ, and TNF-α) that were investigated in the context of CPTP. Multiple cellular signaling pathways and inflammatory cytokines may play an important role in the neuroinflammatory changes associated with the induction and maintenance of chronic post-thoracotomy pain in animal models. However, the clinical impact and therapeutic utility of these neuroinflammatory changes in routine clinical practice have yet to be demonstrated.
慢性开胸术后疼痛(CPTP)是一个主要的临床问题,影响着高达35%-55%的接受胸部切口手术的患者。有证据表明,多种细胞信号通路和神经炎症介质可能在CPTP的发病机制中起重要作用。在这篇综述中,我们介绍了与CPTP的发生和维持相关的细胞信号通路和炎症变化的现有证据,重点关注这些发现在临床环境中的潜在应用。我们对Medline、EMBASE、Cochrane、谷歌学术和ClinicalTrials.gov进行了电子检索,共识别出3652篇摘要。经过初步摘要筛选,131项研究进行了全文审查,最终9篇论文被纳入本综述。如果研究评估了与CPTP的诱导和/或维持相关的细胞信号通路或炎症过程,则纳入研究。所有已识别的研究均为在动物模型上进行的临床前研究。我们的检索确定了在CPTP背景下研究的7条细胞通路(神经激肽-1受体(NK-1)、谷氨酰胺酶1、Toll样受体4(TLR4)、消退素、Ror-2、音猬因子信号通路(Shh)和Wnt5a/Wnts)和6种细胞因子(IL-1β、IL-6、IL-8、IL-10、IFN-γ和TNF-α)。多种细胞信号通路和炎性细胞因子可能在动物模型中与慢性开胸术后疼痛的诱导和维持相关的神经炎症变化中起重要作用。然而,这些神经炎症变化在常规临床实践中的临床影响和治疗效用尚未得到证实。